State Street Corp Spring Works Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,994,000 shares of SWTX stock, worth $141 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,994,000
Previous 2,916,341
2.66%
Holding current value
$141 Million
Previous $129 Million
9.32%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding SWTX
# of Institutions
270Shares Held
71.9MCall Options Held
11.8MPut Options Held
1.27M-
Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY4.11MShares$193 Million6.9% of portfolio
-
Fil LTD Hamilton, D03.01MShares$142 Million0.13% of portfolio
-
Tig Advisors, LLC New York, NY2.61MShares$123 Million6.62% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...